Imaging Biometrics Ltd

Imaging Biometrics Ltd maintains a capital structure characterized by zero long-term debt, resulting in a debt-to-equity ratio of 0.0. However, the company faces significant liquidity constraints, evidenced by a current ratio of 0.55, which indicates that current liabilities exceed current assets. The balance sheet shows total assets of £1,014,130 against total liabilities of £606,500 and total equity of £407,620. Despite positive operating cash flow of £74,340, free cash flow is negative at -£574,180, driven by capital expenditures of -£264,400. The market capitalization stands at £152,960,069, implying a high valuation relative to book value.

Profitability metrics are deeply negative, with a return on equity of -0.8025 and a return on assets of -0.3225. The company reported a net income of -£400,940 and an operating income of -£398,620 for the latest period. While gross profit was positive at £737,270 against revenue of £788,150, indicating a gross margin of approximately 93.5%, the operating losses suggest high operating expenses relative to sales. Without cohort median data for direct comparison, these returns indicate a pre-profitability stage typical of early-stage technology firms, but the negative ROE and ROA highlight the erosion of shareholder value in the current period.

Revenue concentration and geographic exposure details are not provided in the available data. The company’s total revenue for the latest normalized period is £788,150. In the absence of segment or geographic breakdowns, the revenue mix cannot be analyzed for concentration risk. The business appears to rely on a unified revenue stream without disclosed diversification across multiple segments or regions.

Growth trajectory analysis is limited by the absence of historical period data. The current revenue figure of £788,150 provides a single data point. Without 5-year annual or 8-quarter quarterly data, it is not possible to assess revenue trends, growth rates, or consistency of earnings over time. The company’s financial history remains opaque in the provided dataset, preventing a longitudinal assessment of its business development.

Risk assessment indicates low liquidity risk and low dilution risk, with no immediate filing-based flags detected. The low liquidity rating aligns with the current ratio of 0.55, suggesting potential short-term solvency challenges if cash flows do not improve. The low dilution risk is supported by the fact that basic and diluted shares outstanding are identical at 246,709,789, indicating no significant options or convertible securities currently impacting share count. The key flags section confirms no immediate liquidity or dilution threats were identified in recent filings.

Recent events, including filing observations, IR observations, news events, and transcript observations, are not present in the available data. Consequently, there are no recent disclosed events to analyze for their impact on the company’s operations or market perception. The absence of this information limits the ability to contextualize the financial snapshot within recent corporate actions or market developments.

Revenue £750.1k, +23,1% YoY; Operating income +46,7% YoY.

• ▍Revenue £750.1k, +23,1% YoY
• ▍Operating income +46,7% YoY
• ▍Net income +47,6% YoY
• ▍Free cash flow +0,9% YoY
• ▍Net margin -43.6%

Revenue £609.4k, +13,7% YoY; Operating income −22,6% YoY.

• ▍Revenue £609.4k, +13,7% YoY
• ▍Operating income −22,6% YoY
• ▍Net income −21,9% YoY
• ▍Free cash flow −42,8% YoY
• ▍Net margin -102.4%

Revenue £535.9k, +2,8% YoY; Operating income −2,1% YoY.

• ▍Revenue £535.9k, +2,8% YoY
• ▍Operating income −2,1% YoY
• ▍Net income −2,1% YoY
• ▍Free cash flow +3,1% YoY
• ▍Net margin -95.5%